Cloning zebrafish visual system mutants by whole-genome sequencing & SNP mapping
通过全基因组测序克隆斑马鱼视觉系统突变体
基本信息
- 批准号:8518344
- 负责人:
- 金额:$ 18.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-01 至 2015-01-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAge related macular degenerationAnatomyAnimal ModelAnimalsAnteriorBiochemicalBiological AssayBiological ModelsBirthBlindnessCaenorhabditis elegansCataractCell physiologyCellsChildhoodChromosome MappingClinicalCloningCollectionColobomaCongenital DisordersDataDefectDevelopmentDevelopmental BiologyDiseaseDisease modelEthylnitrosoureaEtiologyEye AbnormalitiesGeneticGenetic ScreeningGenomeGlaucomaGrantHereditary DiseaseHumanHuman GeneticsImageLaboratoriesLeadMapsMediatingMethodsModelingMolecularMutateMutationOcular AlbinismOculocutaneous AlbinismOrganPatientsPhenotypePhysiologyPositioning AttributeProcessProteinsReportingResearchResearch PersonnelResolutionRetinal DegenerationRetinitis PigmentosaSingle Nucleotide Polymorphism MapSystemTechniquesTestingTimeTissuesValidationVisual impairmentVisual system structureZebrafishage relatedbaseblindcell typecongenital cataractcostgene discoverygenome sequencinghuman diseasein vivoin vivo Modelinnovationinterestlensmalformationmutantnovelpositional cloningprotein functionresearch studysimple sequence length polymorphism
项目摘要
DESCRIPTION (provided by applicant): Visual impairments affect over 160 million people worldwide, and of these, roughly 37 million are blind (1). Major causes of blindness include cataracts, glaucoma, retinitis pigmentosa and age-related macular degeneration and the development of effective, low-cost therapies for these disorders is of the highest priority. Model organisms with similar anatomy and physiology to humans are vital to understand the molecular and cellular mechanisms underlying these diseases and in which to develop and test potential therapies. The zebrafish, Danio rerio, is an ideal system for modeling human disease, and studies utilizing zebrafish to elucidate the molecular and cellular underpinnings of congenital ocular disorders have made a significant impact in the field. Indeed, the combination of forward genetic screens to identify zebrafish mutants with ocular defects, and the rapid pace of technological advancement in analyzing the mutant phenotypes has positioned the zebrafish system at the forefront of those that contribute to our knowledge of the mechanistic underpinnings of human congenital eye diseases. Research in this grant will utilize an innovative whole-genome sequencing and SNP mapping approach to rapidly and affordably clone recessive zebrafish visual system mutants identified from a recently completed forward genetic screen in our lab. 23 mutants were identified in our screen that presented with congenital cataracts, anterior segment dysgenesis, colobomas, oculocutaneous albinism, retinal degeneration and other developmental defects. Our novel mapping technique will enable us to clone the affected loci in most, if not all, of these mutants and then perform targeted, hypothesis-driven experiments to determine the underlying molecular and cellular mechanisms that lead to ocular defects. We will focus these further research efforts on the congenital cataract mutants. Congenital cataracts occur in ~40 per 100,000 human births and represent the most common cause of childhood blindness in the developed world. Cataracts are also a common clinical feature in nearly 200 different human genetic diseases making them a frequent component of an otherwise heterogeneous collection of disorders. While much is known about age-related and environmentally induced cataracts, less is known about the etiology of congenital cataracts. Thus, the studies proposed here will have significant scientific merit as they will identify gene products required for normal lens development and they will provide animal congenital cataract models through which an understanding of disease mechanism can be can be advanced and a model through which novel therapies can be developed and tested.
描述(由申请人提供):全球有超过1.6亿人受到视力障碍的影响,其中约有3700万人失明(1)。失明的主要原因包括白内障、青光眼、视网膜色素变性和老年性黄斑变性,开发有效、低成本的治疗这些疾病的方法是当务之急。与人类解剖学和生理学相似的模式生物对于了解这些疾病的分子和细胞机制以及开发和测试潜在疗法至关重要。斑马鱼(Danio rerio)是模拟人类疾病的理想系统,利用斑马鱼阐明先天性眼部疾病的分子和细胞基础的研究在该领域产生了重大影响。事实上,识别斑马鱼眼部缺陷突变体的前向基因筛选,以及分析突变表型的快速技术进步,已经将斑马鱼系统定位在那些有助于我们了解人类先天性眼病机制基础的系统的前沿。这项资助的研究将利用创新的全基因组测序和SNP定位方法,快速、经济地克隆从我们实验室最近完成的前向遗传筛选中鉴定出的隐性斑马鱼视觉系统突变体。在我们的筛查中发现了23个突变体,这些突变体表现为先天性白内障、前段发育不良、结肠瘤、眼皮肤白化、视网膜变性和其他发育缺陷。我们的新定位技术将使我们能够克隆大多数(如果不是全部的话)这些突变的受影响基因座,然后进行有针对性的、假设驱动的实验,以确定导致眼部缺陷的潜在分子和细胞机制。我们将把这些进一步的研究重点放在先天性白内障突变体上。先天性白内障发生率约为10万分之40,是发达国家儿童失明的最常见原因。白内障也是近200种不同的人类遗传疾病的常见临床特征,使其成为其他异质性疾病的常见组成部分。虽然对年龄相关和环境诱发的白内障了解很多,但对先天性白内障的病因了解较少。因此,这里提出的研究将具有重要的科学价值,因为它们将确定正常晶状体发育所需的基因产物,并将提供动物先天性白内障模型,通过该模型可以进一步了解疾病机制,并通过该模型可以开发和测试新的治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeffrey Gross其他文献
Jeffrey Gross的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeffrey Gross', 18)}}的其他基金
Elucidating the Molecular Underpinnings of Endogenous RPE Regeneration
阐明内源性 RPE 再生的分子基础
- 批准号:
10179398 - 财政年份:2019
- 资助金额:
$ 18.34万 - 项目类别:
Elucidating the Molecular Underpinnings of Endogenous RPE Regeneration
阐明内源性 RPE 再生的分子基础
- 批准号:
10413980 - 财政年份:2019
- 资助金额:
$ 18.34万 - 项目类别:
Elucidating the Molecular Underpinnings of Endogenous RPE Regeneration
阐明内源性 RPE 再生的分子基础
- 批准号:
10646447 - 财政年份:2019
- 资助金额:
$ 18.34万 - 项目类别:
Elucidating the Molecular Underpinnings of Endogenous RPE Regeneration
阐明内源性 RPE 再生的分子基础
- 批准号:
10746951 - 财政年份:2019
- 资助金额:
$ 18.34万 - 项目类别:
DNA Methylation and Hydroxymethylation During Retinal Development and Stem Cell Maintenance
视网膜发育和干细胞维护过程中的 DNA 甲基化和羟甲基化
- 批准号:
9903328 - 财政年份:2018
- 资助金额:
$ 18.34万 - 项目类别:
DNA Methylation and Hydroxymethylation During Retinal Development and Stem Cell Maintenance
视网膜发育和干细胞维护过程中的 DNA 甲基化和羟甲基化
- 批准号:
10377402 - 财政年份:2018
- 资助金额:
$ 18.34万 - 项目类别:
DNA Methylation and Hydroxymethylation During Retinal Development and Stem Cell Maintenance
视网膜发育和干细胞维护过程中的 DNA 甲基化和羟甲基化
- 批准号:
9776855 - 财政年份:2018
- 资助金额:
$ 18.34万 - 项目类别:
DNA Methylation and Hydroxymethylation During Retinal Development and Stem Cell Maintenance
视网膜发育和干细胞维护过程中的 DNA 甲基化和羟甲基化
- 批准号:
10747714 - 财政年份:2018
- 资助金额:
$ 18.34万 - 项目类别:
Functional analysis of MAB21L2 mutations in MAC spectrum disorders
MAC 谱系疾病中 MAB21L2 突变的功能分析
- 批准号:
9129744 - 财政年份:2015
- 资助金额:
$ 18.34万 - 项目类别:
Functional analysis of MAB21L2 mutations in MAC spectrum disorders
MAC 谱系疾病中 MAB21L2 突变的功能分析
- 批准号:
8951973 - 财政年份:2015
- 资助金额:
$ 18.34万 - 项目类别:
相似海外基金
I(eye)-SCREEN: A real-world AI-based infrastructure for screening and prediction of progression in age-related macular degeneration (AMD) providing accessible shared care
I(eye)-SCREEN:基于人工智能的现实基础设施,用于筛查和预测年龄相关性黄斑变性 (AMD) 的进展,提供可及的共享护理
- 批准号:
10102692 - 财政年份:2024
- 资助金额:
$ 18.34万 - 项目类别:
EU-Funded
Inhibiting Neovascularization and Subretinal Fibrosis in Neovascular Age-Related Macular Degeneration
抑制新生血管性年龄相关性黄斑变性的新生血管形成和视网膜下纤维化
- 批准号:
10639785 - 财政年份:2023
- 资助金额:
$ 18.34万 - 项目类别:
Inhibition of melanogenesis in retinal pigment epithelium, a contributing factor in age-related macular degeneration
抑制视网膜色素上皮中的黑色素生成,这是年龄相关性黄斑变性的一个促成因素
- 批准号:
23K09052 - 财政年份:2023
- 资助金额:
$ 18.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 18.34万 - 项目类别:
Evaluation of New Anti-inflammatory Treatments for Age-Related Macular Degeneration
年龄相关性黄斑变性的新型抗炎治疗方法的评价
- 批准号:
10642988 - 财政年份:2023
- 资助金额:
$ 18.34万 - 项目类别:
Progression of Early Atrophic Lesions in Age-related Macular degeneration
年龄相关性黄斑变性早期萎缩性病变的进展
- 批准号:
10635325 - 财政年份:2023
- 资助金额:
$ 18.34万 - 项目类别:
Cellular and molecular mechanisms of AIM2 and NLRP3 inflammasome activation in age-related macular degeneration
年龄相关性黄斑变性中 AIM2 和 NLRP3 炎症小体激活的细胞和分子机制
- 批准号:
10584110 - 财政年份:2023
- 资助金额:
$ 18.34万 - 项目类别:
Elucidation of roles of mast cells and macrophages in the pathogenesis of age-related macular degeneration
阐明肥大细胞和巨噬细胞在年龄相关性黄斑变性发病机制中的作用
- 批准号:
22H03243 - 财政年份:2022
- 资助金额:
$ 18.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
AMD Mitochondria Modulate Expression of microRNA 135b-5p and 148a-3p in RPE Cybrids: Implications for Age-related Macular Degeneration
AMD 线粒体调节 RPE Cybrids 中 microRNA 135b-5p 和 148a-3p 的表达:对年龄相关性黄斑变性的影响
- 批准号:
10433610 - 财政年份:2022
- 资助金额:
$ 18.34万 - 项目类别:
Targeting the inflammatory response in age-related macular degeneration
针对年龄相关性黄斑变性的炎症反应
- 批准号:
10504138 - 财政年份:2022
- 资助金额:
$ 18.34万 - 项目类别:














{{item.name}}会员




